Yüklüyor......

Guidelines for Osteoprotection in Breast Cancer Patients on an Aromatase Inhibitor

Postmenopausal women are at an increased risk of osteopenia and osteoporosis due to the physiologic loss of the bone protective effects of estrogen. Additionally, disease-related risk factors also contribute to the increased fracture risk. To further complicate matters, one of the most common and se...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yazar: Hadji, Peyman
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: S. Karger GmbH 2010
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3132952/
https://ncbi.nlm.nih.gov/pubmed/21779210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000321426
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!